AAV: Novel Dual-Plasmid Transfection System
Comparison of HIV- and EIAV-Based Vectors on Their Efficiency in Transducing Murine and Human Hematopoietic Repopulating Cells
20th April 2005
Auto‐transduction in lentiviral vector bioprocessing: A quantitative assessment and a novel inhibition strategy
26th August 2024
LV: LentiVector™ Platform
LV: LentiStable™ Packaging and Producer Cell Lines
Assessment of Integration-defective HIV-1 and EIAV Vectors In Vitro and In Vivo
11th December 2012
LV: Clinical & Commercial Manufacturing of Lentiviral Vectors
Analytical characterization of full, intermediate, and empty AAV capsids
19th February 2024
An Improved Helper Plasmid Containing Deletions Within the E4 and E2a Genes Results in Increased Adeno-Associated Virus Productivity
July 13 2024
LV: Analytics for Lentiviral Vectors
A novel dual-plasmid platform provides scalable transfection yielding improved productivity and packaging across multiple AAV serotypes and genomes
June 2023
ALS meets RNAi
April 2005
